Hot Features
Premium
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Period:
Draw Mode:
| Volume | 2,114,042 |
|
|||||
| News | - | ||||||
| Day High | 1.15 | Low High |
|||||
| Day Low | 1.07 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Akebia Therapeutics Inc | AKBA | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.05 | 4.63% | 1.13 | 18:52:30 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.07 | 1.07 | 1.15 | 1.12 | 1.08 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 7,643 | 2,114,042 | US$ 1.12 | US$ 2,373,407 | - | 0.7801 - 2.48 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 18:52:30 | 90 | US$ 1.13 | USD |
Akebia Therapeutics Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 236.59M | 209.37M | - | 194.62M | -51.93M | -0.25 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Akebia Therapeutics News
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical AKBA Price Data
| Period †| Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.08 | 1.15 | 1.00 | 1.06 | 2,517,373 | 0.05 | 4.63% |
| 1 Month | 1.34 | 1.56 | 1.00 | 1.23 | 2,963,856 | -0.21 | -15.67% |
| 3 Months | 1.49 | 2.48 | 1.00 | 1.62 | 5,282,589 | -0.36 | -24.16% |
| 6 Months | 0.9874 | 2.48 | 0.98 | 1.57 | 3,517,304 | 0.1426 | 14.44% |
| 1 Year | 1.115 | 2.48 | 0.7801 | 1.44 | 2,580,576 | 0.015 | 1.35% |
| 3 Years | 3.72 | 4.33 | 0.241 | 1.27 | 3,779,742 | -2.59 | -69.62% |
| 5 Years | 4.74 | 13.78 | 0.241 | 2.38 | 3,525,258 | -3.61 | -76.16% |
Akebia Therapeutics Description
| Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States. |
